| Value | ₹41.87 Cr |
|---|
NSE filing, NSE: SAAKSHI. Summary written from the filing by ALFA Finder's alert engine.
Saakshi Medtech & Panels Ltd: key numbers
- Share price
- ₹364.00
- Market cap
- ₹715.9 Cr
- Revenue (annual)
- ₹115.5 Cr
- Net profit (annual)
- ₹12.29 Cr
- P/E (TTM)
- 58.2×Sector 52.2×
- Promoter holding
- 67.17%-7.65% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saakshi Medtech & Panels Ltd
All →Saakshi Medtech & Panels Annual General Meeting
Saakshi Medtech and Panels Limited held its 17th Annual General Meeting on September 30, 2026, transacting business related to financial statements and director appointments.
Saakshi Medtech & Panels Management Change
Saakshi Medtech and Panels Limited issued a revised disclosure regarding the appointment of Mr. Nandkumar Vasant Dhekne as Independent Director and Mr. Ravi Madhav Vartak as Whole-time Director.
Saakshi Medtech & Panels Capital Structure Change
Saakshi Medtech and Panels Limited received NSE's in-principle approval to list 2,010,259 equity shares of ₹10 each issued via preferential allotment.
Saakshi Medtech & Panels Annual General Meeting
Saakshi Medtech and Panels Limited has scheduled its 17th Annual General Meeting for September 30, 2026. Shareholders will consider financial statements and director appointments.
Saakshi Medtech & Panels Board Meeting Outcome
Saakshi Medtech and Panels Limited announced the re-appointment of Mr. Aniket Latkar as Chairman and Managing Director for a five-year term, effective June 8, 2026.
- Execution
- 5 years
Saakshi Medtech & Panels Capital Structure Change
Saakshi Medtech and Panels Limited approved the preferential allotment of 2,010,259 equity shares at Rs. 207 per share, aggregating to Rs. 41.61 Crore.
- Value
- ₹41.61 Cr
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.